DICARTECH

Davézieux, France

AI / ML

Dicartech is a start-up specialized in health and medical, specifically in the field of vascular medical technologies. Our idea? Propose to all hospital emergency services, a rapid instrument of monitoring patients in septic and hemorrhagic shock and acute circulatory insufficiency, which may cause multi-visceral failures that cause death in some cases. Independent and financed by private funds, our company has launched a very innovative DICART device, able to accurately and automatically measure the TRC (cutaneous recollection time), indicator of good blood circulation. Finished the subjective and imprecise manual assessment of the TRC, measured by a finger pressure on the skin only! We count on you and your financing capacity for this project to become reality and team in the future medical structures. With dicart, it is a new window that opens on the tissue infusion. The purpose of the surveillance is to finalize the launch on the market by Dicartech of a very innovative and easy-to-use instrument (the dicart) to Urgentists, pediatricians, and resusciters. Dicart allows doctors to secure and facilitate their analysis of skin recoluce (CRT) through patented imaging and artificial intelligence techniques. The systematic use of dicart will save 4000 lives per year in France per year and 25,000 in Europe.Https: //www.happy-capital.com/projet/dicartech/pageView a tutorial to help you invest on Happy Capital: https://youtu.be/0sxffk7cy1sdes questions? Contact Dicartech by mail thierry.bouet@dicartech.com on 0602616098 or Happy Capital teams, Monday to Friday, from 9h to 20h, at 09 72 87 37 86 or 06 64 18 95 68